[{"Assets_0_Q3_USD":646508000.0,"CommonStockSharesOutstanding_0_Q3_shares":33245026.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":127102000.0,"NetIncomeLoss_1_Q3_USD":-16502000.0,"NetIncomeLoss_3_Q3_USD":-48214000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":70176000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":206986000.0,"StockholdersEquity_0_Q3_USD":70780000.0,"Ticker":"COLL","CIK":"1267565","name":"COLLEGIUM PHARMACEUTICAL, INC","OfficialName":"Collegium Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"619097451.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]